These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line. Jain SK; Sahu R; Walker LA; Tekwani BL J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents. Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661 [TBL] [Abstract][Full Text] [Related]
4. Repurposing azole antifungals into antileishmanials: Novel 3-triazolylflavanones with promising in vitro antileishmanial activity against Leishmania major. Keighobadi M; Emami S; Fakhar M; Shokri A; Mirzaei H; Hosseini Teshnizi S Parasitol Int; 2019 Apr; 69():103-109. PubMed ID: 30582997 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of in vitro antileishmanial efficacy of cyclosporin A and its non-immunosuppressive derivative, dihydrocyclosporin A. Zheng ZW; Li J; Chen H; He JL; Chen QW; Zhang JH; Zhou Q; Chen DL; Chen JP Parasit Vectors; 2020 Feb; 13(1):94. PubMed ID: 32085719 [TBL] [Abstract][Full Text] [Related]
6. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis. Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627 [TBL] [Abstract][Full Text] [Related]
7. Effect of allicin on promastigotes and intracellular amastigotes of Leishmania donovani and L. infantum. Jesús Corral-Caridad M; Moreno I; Toraño A; Domínguez M; Alunda JM Exp Parasitol; 2012 Dec; 132(4):475-82. PubMed ID: 22995646 [TBL] [Abstract][Full Text] [Related]
8. Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening. Lamotte S; Aulner N; Späth GF; Prina E Sci Rep; 2019 Jan; 9(1):438. PubMed ID: 30679614 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and Antileishmanial Evaluation of Arylimidamide-Azole Hybrids Containing a Phenoxyalkyl Linker. Abdelhameed A; Feng M; Joice AC; Zywot EM; Jin Y; La Rosa C; Liao X; Meeds HL; Kim Y; Li J; McElroy CA; Wang MZ; Werbovetz KA ACS Infect Dis; 2021 Jul; 7(7):1901-1922. PubMed ID: 33538576 [TBL] [Abstract][Full Text] [Related]
10. CYP5122A1 encodes an essential sterol C4-methyl oxidase in Jin Y; Basu S; Feng M; Ning Y; Munasinghe I; Joachim AM; Li J; Madden R; Burks H; Gao P; Perera C; Werbovetz KA; Zhang K; Wang MZ Res Sq; 2023 Jul; ():. PubMed ID: 37546914 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of chalcones as potential antileishmanial agents. Gupta S; Shivahare R; Korthikunta V; Singh R; Gupta S; Tadigoppula N Eur J Med Chem; 2014 Jun; 81():359-66. PubMed ID: 24858541 [TBL] [Abstract][Full Text] [Related]
12. Antileishmanial activity of benzocycloalkyl azole oximino ethers: the conformationally constraint analogues of oxiconazole. Verma A; Srivastava S; Sane SA; Marrapu VK; Srinivas N; Yadav M; Bhandari K; Gupta S Acta Trop; 2011 Feb; 117(2):157-60. PubMed ID: 21078278 [TBL] [Abstract][Full Text] [Related]
13. Eugenol derived immunomodulatory molecules against visceral leishmaniasis. Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085 [TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity. Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987 [TBL] [Abstract][Full Text] [Related]
15. Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis. Chakrabarti G; Basu A; Manna PP; Mahato SB; Mandal NB; Bandyopadhyay S J Antimicrob Chemother; 1999 Mar; 43(3):359-66. PubMed ID: 10223591 [TBL] [Abstract][Full Text] [Related]
16. Chlorogenic acid acts upon Leishmania donovani arresting cell cycle and modulating cytokines and nitric oxide in vitro. Majumder N; Ganguly S; Ghosh AK; Kundu S; Banerjee A; Saha S Parasite Immunol; 2020 Jun; 42(6):e12719. PubMed ID: 32248547 [TBL] [Abstract][Full Text] [Related]
17. Enhanced Glycolysis Is Required for Antileishmanial Functions of Neutrophils Upon Infection With Ohms M; Ferreira C; Busch H; Wohlers I; Guerra de Souza AC; Silvestre R; Laskay T Front Immunol; 2021; 12():632512. PubMed ID: 33815385 [TBL] [Abstract][Full Text] [Related]
18. Using a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotes. Paape D; Bell AS; Heal WP; Hutton JA; Leatherbarrow RJ; Tate EW; Smith DF PLoS Negl Trop Dis; 2014 Dec; 8(12):e3363. PubMed ID: 25522361 [TBL] [Abstract][Full Text] [Related]
19. Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target. Jaiswal AK; Rao KB; Kushwaha P; Rawat K; Modukuri RK; Khare P; Joshi S; Mishra S; Rai A; Sashidhara KV; Dube A Int J Antimicrob Agents; 2016 Dec; 48(6):695-702. PubMed ID: 27876275 [TBL] [Abstract][Full Text] [Related]
20. Identification of new antileishmanial leads from hits obtained by high-throughput screening. Zhu X; Pandharkar T; Werbovetz K Antimicrob Agents Chemother; 2012 Mar; 56(3):1182-9. PubMed ID: 22143523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]